Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 178

1.

[Recomendaciones a los cuerpos directivos de las agrupaciones médicas en su relación con la industria].

Soda A, Campillo C, Arrieta O, Burgos R, Celis MÁ, Llata M, Domínguez J, Halabe J, Islas S, Jasso L, Lifshitz A, Moreno M, Plancarte R, Reyes A, Ruiz-Argüelles GJ, Verástegui E, Sotelo J.

Gac Med Mex. 2018;154(5):622-623. doi: 10.24875/GMM.18004653. Spanish.

PMID:
30407458
2.

EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP).

Ruiz-Patiño A, Castro CD, Ricaurte LM, Cardona AF, Rojas L, Zatarain-Barrón ZL, Wills B, Reguart N, Carranza H, Vargas C, Otero J, Corrales L, Martín C, Archila P, Rodriguez J, Avila J, Bravo M, Pino LE, Rosell R, Arrieta O; Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).

Target Oncol. 2018 Oct;13(5):621-629. doi: 10.1007/s11523-018-0594-x.

PMID:
30284706
3.

FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients.

Turcott JG, Oñate-Ocaña LF, Soca-Chafre G, Ramírez-Tirado LA, Flores-Estrada D, Zatarain-Barrón ZL, Arrieta O.

Nutr Cancer. 2018 Oct 1:1-9. doi: 10.1080/01635581.2018.1506488. [Epub ahead of print]

PMID:
30273069
4.

Probable hereditary familial overlap syndrome with multiple synchronous lung tumors.

Cardona AF, Zatarain-Barrón ZL, Rubio C, Martínez S, Ruiz-Patiño A, Ricaurte L, Serna A, Barrios R, Garzón JC, Navarrete C, Balaguera A, Corrales L, Rojas L, Arrieta O.

Lung Cancer. 2018 Oct;124:279-282. doi: 10.1016/j.lungcan.2018.08.022. Epub 2018 Aug 28.

PMID:
30268473
5.

Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico.

Verástegui E, Plancarte R, Domínguez J, Burgos R, Arrieta O, Campillo C, Celis MÁ, la-Llata M, Halabe J, Islas S, Jasso L, Lifshitz A, Moreno M, Reyes A, Ruiz-Argüelles G, Soda A, Sotelo J.

Gac Med Mex. 2018;154(4):532-533. doi: 10.24875/GMM.18003760.

6.

Sugerencias en torno a medicamentos de efectividad demostrada sin interés comercial para la industria farmacéutica.

Llata M, Hálabe J, Plancarte R, Arrieta O, Burgos R, Campillo C, Celis MÁ, Domínguez J, Islas S, Jasso L, Lifshitz A, Moreno M, Reyes A, Ruiz-Argüelles G, Soda A, Verástegui E, Sotelo J.

Gac Med Mex. 2018;154(4):534-536. doi: 10.24875/GMM.17003670.

7.

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.

Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Lazar AJ, Somaiah N, Roszik J, Patel SR.

J Glob Oncol. 2018 Sep;(4):1-6. doi: 10.1200/JGO.2017.009993. Epub 2017 Jul 6. No abstract available.

8.

Comprehensive review of fetal adenocarcinoma of the lung.

Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF.

Lung Cancer (Auckl). 2018 Aug 23;9:57-63. doi: 10.2147/LCTT.S137410. eCollection 2018. Review.

9.

Robust PI/PID controllers for load disturbance based on direct synthesis.

Vilanova R, Arrieta O, Ponsa P.

ISA Trans. 2018 Oct;81:177-196. doi: 10.1016/j.isatra.2018.07.040. Epub 2018 Aug 11.

PMID:
30146084
10.

Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients.

Soca-Chafre G, Hernández-Pedro N, Aviles-Salas A, Versón CA, Sánchez KC, Cardona AF, Avila-Moreno F, Barrios-Bernal P, Flores-Estrada D, Arrieta O.

Oncotarget. 2018 Jul 17;9(55):30499-30512. doi: 10.18632/oncotarget.25369. eCollection 2018 Jul 17.

11.

Correction to: Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

Bautista RR, Gómez AO, Miranda AH, Dehesa AZ, Villarreal-Garza C, Ávila-Moreno F, Arrieta O.

Clin Epigenetics. 2018 Aug 8;10(1):106. doi: 10.1186/s13148-018-0537-5.

12.

Extended resections of large thymomas: importance of en bloc thymectomy.

Corona-Cruz JF, López-Saucedo RA, Ramírez-Tirado LA, Pérez-Montiel D, González-Luna JA, Jiménez-Fuentes E, Arrieta O.

J Thorac Dis. 2018 Jun;10(6):3473-3481. doi: 10.21037/jtd.2018.05.101.

13.

Factors associated with long-term survival in central nervous system metastases.

Cacho-Díaz B, Spínola-Maroño H, González-Aguilar A, Arrieta O.

J Neurooncol. 2018 Oct;140(1):159-164. doi: 10.1007/s11060-018-2946-x. Epub 2018 Jul 12.

PMID:
30003395
14.

Myasthenia gravis as a prognostic marker in patients with thymoma.

Cacho-Díaz B, Salmerón-Moreno K, Lorenzana-Mendoza NA, Texcocano J, Arrieta O.

J Thorac Dis. 2018 May;10(5):2842-2848. doi: 10.21037/jtd.2018.04.95.

15.

Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.

Arrieta O, Luvián-Morales J, Turcott JG, Oñate-Ocaña LF.

Qual Life Res. 2018 Jul 10. doi: 10.1007/s11136-018-1930-4. [Epub ahead of print]

PMID:
29987501
16.

Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

Rodríguez Bautista R, Ortega Gómez A, Hidalgo Miranda A, Zentella Dehesa A, Villarreal-Garza C, Ávila-Moreno F, Arrieta O.

Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018. Review. Erratum in: Clin Epigenetics. 2018 Aug 8;10(1):106.

17.

Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.

Torre-Bouscoulet L, Arroyo-Hernández M, Martínez-Briseño D, Muñoz-Montaño WR, Gochicoa-Rangel L, Bacon-Fonseca L, Pérez-Padilla R, Vergara E, García-Sancho C, Lozano-Ruiz F, Fernández-Plata R, Guzmán-Barragán A, Arrieta O.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):910-918. doi: 10.1016/j.ijrobp.2018.04.014. Epub 2018 Apr 12.

PMID:
29976503
18.

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.

Barrera L, Montes-Servín E, Hernandez-Martinez JM, Orozco-Morales M, Montes-Servín E, Michel-Tello D, Morales-Flores RA, Flores-Estrada D, Arrieta O.

Cancer Immunol Immunother. 2018 Sep;67(9):1393-1406. doi: 10.1007/s00262-018-2196-y. Epub 2018 Jul 4.

PMID:
29974189
19.

Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation.

Barrón F, Cardona AF, Corrales L, Ramirez-Tirado LA, Caballe-Perez E, Sanchez G, Flores-Estrada D, Zatarain-Barrón ZL, Arrieta O; Latin American Consortium for the Study of Lung Cancer (CLICaP).

J Thorac Dis. 2018 Apr;10(4):2166-2178. doi: 10.21037/jtd.2018.03.106.

20.

Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century.

Barrón F, Zatarain-Barrón ZL, Cardona AF, Arrieta O.

J Thorac Dis. 2018 Mar;10(3):1265-1268. doi: 10.21037/jtd.2018.03.28. No abstract available.

Supplemental Content

Loading ...
Support Center